The Scourge of MRSA

Or log in to access your purchased courses
After completion of this course you will receive 3 Continuing Education Units
Is this course for me? This course is for RNs, LVNs, Psych Techs, Administrators & Workers for Adult Residential Facilities, Residential Facilities for the Elderly & Group Homes
Course Synopsis:

   First noticed in nursing hospitals in the early 1960′s, MRSA has had a relatively short existence. Until the mid-20th century, infectious diseases were the leading cause of death. Thanks to our good friend Alexander Fleming’s accidental discovery of penicillin in 1928, history shows a huge decrease in the incidences of diseases caused by bacteria throughout the early 20th century. Fleming’s discovery took a little while to gain traction, but when it did in the early 1940′s, it kick-started the era of the “Antibiotic Phenomenon”. Hailed as miracle drugs, these simple pills provided remarkable cures for previously untreatable conditions. Unfortunately, antibiotics do not provide a happily-ever-after story.

   Just a decade later, a resistant strain of Staphylococcus Aureus emerged. It not only showed resistance to penicillin, but also to newer antibiotics in development such as: erythromycin, streptomycin, and tetracycline. The emergence of this super bacteria afforded a very costly lesson: Bacteria have the ability to mutate. Learn more about this superbug as seasoned, Registered Nurse, Donn Kropp, demystifies this scourge.

Sample CEU Certificate for ClickPlayCEU

Sample CEU Certificate

Course Objectives:  Upon completion of this course you will be able to:

  • Understand bacteria and their significance
  • Differentiate between Staphylococcus Aureus and MRSA
  • Understand the origins of MRSA and its ramifications on health
  • Gain knowledge about colonization vs infection
  • Be enlightened about the mechanisms of bacterial mutation and resistance
  • Learn how to identify, manage and prevent MRSA infections
  • Understand treatment options
  • Know the importance of instituting safe and effective infection control practices

Course Instructor Profile:

 Donn Kropp founded CLiCKPLAY Continuing Education University out of a desire to bring others to greater levels of health and wellness. With over ten years of emergency and trauma room experience, Donn brings a seasoned, yet fresh approach to continuing education.

Course Approvals

This course is approved by the following governing boards & organizations:

  • CA Board of Registered Nursing: CA Provider # CEP 15849
  • District of Columbia Board of Nursing: CE Provider #50-14108
  • California Board of Vocational Nursing Provider # V10810
  • Psychiatric Technicians Provider # V10806
  • DSS/CCL Division for Adult Residential Facilities (ARF) Vendor Approval # 2000149-735-2: Course Approval # 149-0312-24234
  • DSS/CCL Division for Residential Facilities for the Elderly (RCFE) Vendor Approval # 2000149-740-2: Course Approval # 149-0312-24238
  • DSS/CCL Division for Group Homes (GH) Vendor Approval # 2000149-730-2: Course Approval # 149-0312-24230
  • Far Northern Regional Center


Enter Transcript Here

Writers and References

Writer(s): Donn Kropp, RN, BSN


  • Jevons MP, Coe AW, Parker MT. Methicillin resistance in staphylococci. Lancet. Apr 27 1963;1:904-7.
  • Elston DM. Handling a community-acquired methicillin-resistant Staphylococcus aureus outbreak: emerging data. Cutis. Aug 2008;82(2 Suppl 2):13-7
  • Frazee BW, Lynn J, Charlebois ED, et al. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med. Mar 2005;45(3):311-20.
  • Wulf MW, Sorum M, van Nes A, et al. Prevalence of methicillin-resistant Staphylococcus aureus among veterinarians: an international study. Clin Microbiol Infect. Jan 2008;14(1):29-34
  • Tacconelli E. Methicillin-resistant Staphylococcus aureus: risk assessment and infection control policies. Clin Microbiol Infect. Jan 11 2008;epub ahead of print.
  • Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18-e55.


Staph vs MRSA

Length: 15 minutes

In this lesson we explore the difference between staphylococcus and MRSA.

Mutation & Resistance

Length: 23 minutes

This lesson explores how bacteria mutate and develop resistance to treatment.

Treatment Options

Length: 25 minutes

In this lesson we’ll explore some treatment options for MRSA infections.

Conclusion & Final Quiz

Length: 27 minutes

This lesson summarizes and concludes our course on MRSA. Once you complete the quiz get your certificate of completion instantly!